Increased thrombin generation and complement activation in patients with type IIA hyperlipoproteinemia: effects of simvastatin treatment
- 31 October 1997
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 58 (10) , 706-723
- https://doi.org/10.1016/s0011-393x(97)80105-1
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusionBlood Coagulation & Fibrinolysis, 1993
- Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)Atherosclerosis, 1992
- Hypertriglyceridemia and regulation of fibrinolytic activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Association of serum IgA and C4 with severe atherosclerosisAtherosclerosis, 1988
- The complement system in atherosclerosisAtherosclerosis, 1988
- Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Increased platelet sensitivity and thromboxane B2 formation in type‐II hyperlipoproteinaemic patientsEuropean Journal of Clinical Investigation, 1984
- Classification of Hyperlipidemias and HyperlipoproteinemiasCirculation, 1972
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965